Drug name - Zerit Xr

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7135465 BRISTOL MYERS SQUIBB Sustained release beadlets containing stavudine Feb, 2023

(4 months from now)

US7135465

(Pediatric)

BRISTOL MYERS SQUIBB Sustained release beadlets containing stavudine Aug, 2023

(10 months from now)

Drugs and Companies using STAVUDINE ingredient

Treatment: Method for treating hiv-1 infection

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
37.5MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
50MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
75MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
100MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.